Risk of invasive cervical cancer after pap smears: The protective effect of multiple negatives

Journal of Medical Screening

Volumn 12, Issue 1, 2005, Pages 7-11

  Coldman, Andrew ^a   Phillips, Norm ^a   Kan, Lisa ^a   Matisic, Jasenka ^a   Benedet, Lou ^a   Towers, Laura ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CANADA; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COHORT ANALYSIS; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; UTERINE CERVIX CANCER;

ADULT; AGED; BRITISH COLUMBIA; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 15944411055     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/0969141053279103     Document Type: Article

References (19)

1. Hakama M, Magnus K, Petterson F, et al. Effect of organised screening on the risk of cervical cancer in the Nordic countries, in Cancer Screening In: Miller A et al., eds. Cambridge University Press: Cambridge, 1991;153-62
2. Anderson G, Benedet J, LeRiche J, et al. Cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases from 1985-88. Obstetr Gynecol 1992;80:1-4
3. Boyes D, Nichols T, Millner A, Worth A. Recent results from the British Columbia screening program for cervical cancer. Am J Otstetr Gynecol 1977;128:692-3
4. IARC Working Group on the Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986;293:659-64
5. Hakama M, Louhivuori K. A screening program for cervical cancer that worked. Cancer Surv 1988;7:403-16
6. Saslow D, Runowicz C, Solomon D, et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62
7. Miller A, Nazeer S, Fonn S, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86:440-7
8. Sasieni P, Cuzick J, Lynch-Farmery L, N.C. -o.n.f.C.S.W. group. Estimating the efficacy of screening by auditing histories of women with and without cervical cancer. Br J Cancer 1996;73:1001-3
9. Coldman AJ, Phillips N, Kan L, et al. Risk of invasive cervical cancer after three consecutive negative Pap smears. J Med Screen 2003;10:196-200
10. Therneau T, Grambsch P. Modelling Survival Data: Extending the Cox Model. New York: Springer, 2000
11. Cervical Cancer Screening Program. Annual Report. Vancouver: BC Cancer Agency, 2001;7
12. Smith R, von Eschenbach A, Wender R, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2001;51:38-75
13. Miller A, Anderson G, Brisson J, et al. Report of a National Workshop on screening for cancer of the cervix. Canad Med Assoc J 1991;145:1301-25
14. Nanda K, McCrory D, Myers E, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9
15. Boyes D, Morrison B, Knox E, et al. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 1982;5:1-29
16. Schiffman M, Brinton L. The epidemiology of cervical carcinogenesis. Cancer 1995;76:1888-901
17. Franco E, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and role of human Papilloma virus infection. Canad Med Assoc J 2001;164:1017-25
18. Sawaya G, McConnell K, Kulasingham S, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003;349:1501-9
19. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93